hesim: Health Economic Simulation Modeling and Decision Analysis
暂无分享,去创建一个
[1] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[2] David R. Cox,et al. The Theory of Stochastic Processes , 1967, The Mathematical Gazette.
[3] Malcolm J Price,et al. Parameterization of treatment effects for meta‐analysis in multi‐state Markov models , 2011, Statistics in medicine.
[4] Hein Putter,et al. mstate: An R Package for the Analysis of Competing Risks and Multi-State Models , 2011 .
[5] Gianluca Baio,et al. R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] Doug Coyle,et al. A technique for approximating transition rates from published survival analyses , 2019, Cost Effectiveness and Resource Allocation.
[7] Gianluca Baio,et al. Bayesian Methods in Health Economics , 2012 .
[8] J. de Haes,et al. Quality-adjusted survival analysis. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Nicky J Welton,et al. Network Meta-Analysis for Decision-Making , 2018 .
[10] N. Devlin,et al. The Influence of Cost-Effectiveness and Other Factors on NICE Decisions , 2010, Health economics.
[11] S. Chick,et al. A taxonomy of model structures for economic evaluation of health technologies. , 2006, Health economics.
[12] Allan Wailoo,et al. The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis , 2013, Rheumatology.
[13] Matt Stevenson,et al. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. , 2007, Health economics.
[14] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[15] Gianluca Baio,et al. Bayesian Cost-Effectiveness Analysis with the R package BCEA , 2017 .
[16] S. Griffin,et al. Distributional cost-effectiveness analysis: a tutorial , 2016 .
[17] Devin Incerti,et al. Multi-state network meta-analysis of cause-specific survival data , 2020, medRxiv.
[18] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[19] Simon G Thompson,et al. Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. , 2005, Health economics.
[20] Claire Williams,et al. Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.
[21] Marta Soares,et al. Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now? , 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[22] Ren Johansen. An Empirical Transition Matrix for Non-homogeneous Markov Chains Based on Censored Observations , 1978 .
[23] Gianluca Baio,et al. survHE: Survival Analysis for Health Economic Evaluation and Cost-Effectiveness Modeling , 2020, J. Stat. Softw..
[24] Anthony O'Hagan,et al. Modelling SF-6D health state preference data using a nonparametric Bayesian method. , 2007, Journal of health economics.
[25] O. Norheim,et al. Using Cost-Effectiveness Analysis to Address Health Equity Concerns , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] Hein Putter,et al. Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models. , 2008, Statistics in medicine.
[27] Fernando Alarid-Escudero,et al. An Overview of R in Health Decision Sciences , 2017, Medical decision making : an international journal of the Society for Medical Decision Making.
[28] Christopher H Jackson,et al. flexsurv: A Platform for Parametric Survival Modeling in R. , 2016, Journal of statistical software.
[29] Gianluca Baio,et al. When Simple Becomes Complicated: Why Excel Should Lose its Place at the Top Table , 2019, Global and Regional Health Technology Assessment.
[30] Isabelle Durand-Zaleski,et al. Markov Models for Health Economic Evaluations: The R Package heemod , 2017, 1702.03252.
[31] Gianluca Baio,et al. Efficient Monte Carlo Estimation of the Expected Value of Sample Information Using Moment Matching , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.
[32] Andrew Briggs,et al. An Introduction to Markov Modelling for Economic Evaluation , 1998, PharmacoEconomics.
[33] Nicky J Welton,et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves , 2012, BMC Medical Research Methodology.
[34] P Glasziou,et al. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] M. Sculpher,et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. , 2005, Health economics.
[36] Jeremy E. Oakley,et al. Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[37] Eleftherios Sideris,et al. NICE DSU TECHNICAL SUPPORT DOCUMENT 19 : PARTITIONED SURVIVAL ANALYSIS FOR DECISION MODELLING IN HEALTH CARE : A CRITICAL REVIEW REPORT BY THE DECISION SUPPORT UNIT 2 June 2017 , 2017 .
[38] Pedro M. Valero-Mora,et al. ggplot2: Elegant Graphics for Data Analysis , 2010 .
[39] K. Phillips,et al. Health technology assessment and private payers' coverage of personalized medicine. , 2011, Journal of oncology practice.